Research Team

Bethany McLeman, BA

Research Project Director, Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, Center for Technology and Behavioral Health

Communications; Substance Use Disorder; Opioid Epidemic; Health Technology

Contact

Bethany McLeman, BA
Research Project Director, Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, Center for Technology and Behavioral Health

46 Centerra Parkway, Suite 315, Lebanon, NH 03766

Bethany.M.McLeman@Dartmouth.edu


Bethany is engaged in research administration and program management with the Northeast Node of the Clinical Trials Network and Center for Technology and Behavioral Health. Bethany graduated Cum Laude with a BA in English from Keene State College. Before joining the CTN, Bethany managed multiple concurrent learning collaborates and federally-funded studies in addictions research. Bethany’s professional experiences include grant development and management, technology, administration, database design and maintenance, and communication coordination of large networks of researchers. Bethany was born in New Hampshire and is dedicated to helping improve primary care treatment to better impact people with substance use disorders, their families, and their communities. Bethany enjoys spending time outside with her family, both two- and four-legged members, and is always ready to go to the beach.


Selected Publications
  • type-published
    1448928000
    12
    2015
    Saunders EC, McGovern MP, Lambert-Harris C, Meier A, McLeman B, Xie H. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict. 2015 Dec;24(8):722-31. doi: 10.1111/ajad.12292. PMID: 26388539; PMCID: PMC4866634.
    View Source
  • type-published
    1439856000
    8
    2015
    Meier A, McGovern MP, Lambert-Harris C, McLeman B, Franklin A, Saunders EC, Xie H. Adherence and competence in two manual-guided therapies for co-occurring substance use and posttraumatic stress disorders: Clinician factors and patient outcomes. Am J Drug Alcohol Abuse. 2015;41(6):527-34. doi: 10.3109/00952990.2015.1062894. PMID: 26286351; PMCID: PMC4698972.
    View Source
  • type-published
    1435708800
    7
    2015
    McGovern MP, Lambert-Harris C, Xie H, Meier A, McLeman B, Saunders E. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251; PMCID: PMC4478141.
    View Source
  • type-published
    1422748800
    2
    2015
    Saunders EC, McLeman BM, McGovern MP, Xie H, Lambert-Harris C, Meier A. The influence of family and social problems on treatment outcomes of persons with co-occurring substance use disorders and PTSD. J Subst Use. 2016;21(3):237-243. doi: 10.3109/14659891.2015.1005184. PMID: 27182200; PMCID: PMC4864012.
    View Source
  • type-published
    1404172800
    7
    2014
    Meier A, Lambert-Harris C, McGovern MP, Xie H, An M, McLeman B. Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. Am J Drug Alcohol Abuse. 2014 Jul;40(4):304-11. doi: 10.3109/00952990.2014.910519. PMID: 24809229; PMCID: PMC4883674.
    View Source